Lifestyle
US antibody firm: Human preliminaries could be held in Israel as disease rates rise
After Jerusalem marked restricting term sheet for acquisition of medication, CEO of Arcturus Therapeutics says Phase 3 investigation should be held in area with significant number of cases The top of a US firm building up a COVID-19 antibody said Sunday that as contamination paces of the coronavirus ascend in Read more…